Bengaluru, July 11 -- The shares of the prominent pharmaceutical company broke the upper band, gained up to 15 percent in today's trading session after the company's subsidiary of Ichnos Glenmark Innovation Inc., entered into a major licensing deal with AbbVie.

With a market capitalization of Rs 59,139.41 crore, the shares of Glenmark Pharmaceuticals Ltd were trading at Rs 2,095.65 per share, increasing around 10 percent as compared to the previous closing price of Rs 1905.15 apiece.

The shares of Glenmark Pharmaceuticals Ltd have seen bullish movement after IGI Therapeutics SA, a subsidiary of Ichnos Glenmark Innovation Inc., has entered into a major licensing deal with AbbVie for its lead oncology and autoimmune drug candidate, ISB 20...